LPU
Lansdowne Partners (UK)’s Summit Therapeutics SMMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,667,350
| Closed | -$7.92M | – | 47 |
|
|
2020
Q2 | $7.92M | Sell |
2,667,350
-1,561,350
| -37% | -$4.64M | 0.33% | 28 |
|
|
2020
Q1 | $10M | Buy |
4,228,700
+2,632,034
| +165% | +$6.24M | 0.56% | 18 |
|
|
2019
Q4 | $2.56M | Hold |
1,596,666
| – | – | 0.07% | 22 |
|
|
2019
Q3 | $2.86M | Hold |
1,596,666
| – | – | 0.08% | 26 |
|
|
2019
Q2 | $2.02M | Hold |
1,596,666
| – | – | 0.05% | 24 |
|
|
2019
Q1 | $2.92M | Hold |
1,596,666
| – | – | 0.06% | 29 |
|
|
2018
Q4 | $1.84M | Hold |
1,596,666
| – | – | 0.03% | 31 |
|
|
2018
Q3 | $3.55M | Hold |
1,596,666
| – | – | 0.04% | 31 |
|
|
2018
Q2 | $3.91M | Hold |
1,596,666
| – | – | 0.04% | 35 |
|
|
2018
Q1 | $20.6M | Hold |
1,596,666
| – | – | 0.21% | 17 |
|
|
2017
Q4 | $17.7M | Hold |
1,596,666
| – | – | 0.16% | 22 |
|
|
2017
Q3 | $20M | Buy |
1,596,666
+666,666
| +72% | +$8.37M | 0.21% | 17 |
|
|
2017
Q2 | $10.6M | Hold |
930,000
| – | – | 0.09% | 23 |
|
|
2017
Q1 | $12.3M | Hold |
930,000
| – | – | 0.11% | 21 |
|
|
2016
Q4 | $7.96M | Hold |
930,000
| – | – | 0.07% | 21 |
|
|
2016
Q3 | $8.43M | Hold |
930,000
| – | – | 0.07% | 18 |
|
|
2016
Q2 | $7.52M | Hold |
930,000
| – | – | 0.07% | 21 |
|
|
2016
Q1 | $6.34M | Hold |
930,000
| – | – | 0.05% | 22 |
|
|
2015
Q4 | $10.7M | Hold |
930,000
| – | – | 0.07% | 22 |
|
|
2015
Q3 | $9.68M | Hold |
930,000
| – | – | 0.08% | 22 |
|
|
2015
Q2 | $9.82M | Hold |
930,000
| – | – | 0.08% | 21 |
|
|
2015
Q1 | $11.5M | Buy |
+930,000
| New | +$11.5M | 0.1% | 21 |
|